Strategic funding OBIO operates as a not-for-profit, membership-based organization that supports early-stage and venture-backed life sciences and health tech companies to raise capital and access infrastructure, signaling opportunities to engage with a network of emerging companies and potential co-funding or partnership programs.

Clinical development Positioned as an innovation and clinical development platform for medical devices with partnerships and potential pivotal trial readouts, there is a sales opportunity to offer strategic services, regulatory guidance, and MVP development support to device developers seeking commercialization pathways.

Industry partnerships OBIO collaborates with industry, academia, healthcare systems and government; selling points include access to diversified ecosystems, co-development opportunities, and channels to reach hospital systems and payer networks for market adoption strategies.

Commercialization readiness OBIO helps member companies facilitate commercialization and market adoption in health systems, suggesting opportunities to offer go-to-market planning, health economics, reimbursement strategy, and payer engagement services.

Public market visibility Recent Nasdaq and Russell index activity indicates OBIO’s high-visibility and investor interest; sales conversations can emphasize strategic partnerships, funding rounds, and access to investor conferences as avenues to accelerate portfolio company growth.